BioCentury
ARTICLE | Company News

TesoRx, Aska deal

January 27, 2017 9:07 PM UTC

TesoRx granted Aska an exclusive option to develop and commercialize THG-1001 in Japan. TesoRx will receive an undisclosed upfront payment and is eligible for milestones and royalties. THG-1001, an or...